PD1 gene (Pdcd1) disruption using CRISPR/Cas9 in anti-CD133 CAR T cells was shown to increase tumor killing in vitro while inhibiting in vivo tumor growth in a orthotopic glioma xenograft model (233). The gene discussed is PROM1; the disease is neoplasm.